OncoRTT: Predicting novel oncology-related therapeutic targets using BERT embeddings and omics features.
Ontology highlight
ABSTRACT: Late-stage drug development failures are usually a consequence of ineffective targets. Thus, proper target identification is needed, which may be possible using computational approaches. The reason being, effective targets have disease-relevant biological functions, and omics data unveil the proteins involved in these functions. Also, properties that favor the existence of binding between drug and target are deducible from the protein's amino acid sequence. In this work, we developed OncoRTT, a deep learning (DL)-based method for predicting novel therapeutic targets. OncoRTT is designed to reduce suboptimal target selection by identifying novel targets based on features of known effective targets using DL approaches. First, we created the "OncologyTT" datasets, which include genes/proteins
SUBMITTER: Thafar MA
PROVIDER: S-EPMC10117673 | biostudies-literature | 2023
REPOSITORIES: biostudies-literature
ACCESS DATA